180 related articles for article (PubMed ID: 12734639)
1. Contribution of CYP2E1 to N-methyl-2-pyrrolidone metabolism.
Ligocka D; Lison D; Haufroid V
Arch Toxicol; 2003 May; 77(5):261-6. PubMed ID: 12734639
[TBL] [Abstract][Full Text] [Related]
2. Human volunteer study on the influence of exposure duration and dilution of dermally applied N-methyl-2-pyrrolidone (NMP) on the urinary elimination of NMP metabolites.
Keener SA; Wrbitzky R; Bader M
Int Arch Occup Environ Health; 2007 Feb; 80(4):327-34. PubMed ID: 16897094
[TBL] [Abstract][Full Text] [Related]
3. Levels of N-methyl-2-pyrrolidone (NMP) and its metabolites in plasma and urine from volunteers after experimental exposure to NMP in dry and humid air.
Carnerup MA; Spanne M; Jönsson BA
Toxicol Lett; 2006 Apr; 162(2-3):139-45. PubMed ID: 16321482
[TBL] [Abstract][Full Text] [Related]
4. Human experimental exposure study on the uptake and urinary elimination of N-methyl-2-pyrrolidone (NMP) during simulated workplace conditions.
Bader M; Wrbitzky R; Blaszkewicz M; van Thriel C
Arch Toxicol; 2007 May; 81(5):335-46. PubMed ID: 17103143
[TBL] [Abstract][Full Text] [Related]
5. Major metabolic pathway for N-methyl-2-pyrrolidone in humans.
Akesson B; Jönsson BA
Drug Metab Dispos; 1997 Feb; 25(2):267-9. PubMed ID: 9029058
[TBL] [Abstract][Full Text] [Related]
6. Human CYP2E1 mediates the formation of glycidamide from acrylamide.
Settels E; Bernauer U; Palavinskas R; Klaffke HS; Gundert-Remy U; Appel KE
Arch Toxicol; 2008 Oct; 82(10):717-27. PubMed ID: 18418580
[TBL] [Abstract][Full Text] [Related]
7. Dermal exposure to aqueous solutions of N-methyl pyrrolidone.
Akrill P; Cocker J; Dixon S
Toxicol Lett; 2002 Aug; 134(1-3):265-9. PubMed ID: 12191887
[TBL] [Abstract][Full Text] [Related]
8. Human experimental exposure to N-methyl-2-pyrrolidone (NMP): toxicokinetics of NMP, 5-hydroxy- N-methyl-2-pyrrolidone, N-methylsuccinimide and 2-hydroxy- N-methylsuccinimide (2-HMSI), and biological monitoring using 2-HMSI as a biomarker.
Jönsson BA; Akesson B
Int Arch Occup Environ Health; 2003 May; 76(4):267-74. PubMed ID: 12684812
[TBL] [Abstract][Full Text] [Related]
9. Human volunteer study on the inhalational and dermal absorption of N-methyl-2-pyrrolidone (NMP) from the vapour phase.
Bader M; Wrbitzky R; Blaszkewicz M; Schäper M; van Thriel C
Arch Toxicol; 2008 Jan; 82(1):13-20. PubMed ID: 17721780
[TBL] [Abstract][Full Text] [Related]
10. Dermal absorption and urinary elimination of N-methyl-2-pyrrolidone.
Bader M; Keener SA; Wrbitzky R
Int Arch Occup Environ Health; 2005 Sep; 78(8):673-6. PubMed ID: 16001206
[TBL] [Abstract][Full Text] [Related]
11. Toxicokinetics and metabolism of N-[(14)C]N-methyl-2-pyrrolidone in male Sprague-Dawley rats: in vivo and in vitro percutaneous absorption.
Payan JP; Boudry I; Beydon D; Fabry JP; Grandclaude MC; Ferrari E; André JC
Drug Metab Dispos; 2003 May; 31(5):659-69. PubMed ID: 12695356
[TBL] [Abstract][Full Text] [Related]
12. Concentrations of N-methyl-2-pyrrolidone (NMP) and its metabolites in plasma and urine following oral administration of NMP to rats.
Carnerup MA; Saillenfait AM; Jönsson BA
Food Chem Toxicol; 2005 Sep; 43(9):1441-7. PubMed ID: 15951091
[TBL] [Abstract][Full Text] [Related]
13. Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1.
Kharasch ED; Hankins DC; Jubert C; Thummel KE; Taraday JK
Drug Metab Dispos; 1999 Jun; 27(6):717-23. PubMed ID: 10348802
[TBL] [Abstract][Full Text] [Related]
14. In vitro metabolism and covalent binding of ethylbenzene to microsomal protein as a possible mechanism of ethylbenzene-induced mouse lung tumorigenesis.
Saghir SA; Zhang F; Rick DL; Kan L; Bus JS; Bartels MJ
Regul Toxicol Pharmacol; 2010; 57(2-3):129-35. PubMed ID: 20096743
[TBL] [Abstract][Full Text] [Related]
15. The metabolic rate constants and specific activity of human and rat hepatic cytochrome P-450 2E1 toward toluene and chloroform.
Lipscomb JC; Barton HA; Tornero-Velez R; Evans MV; Alcasey S; Snawder JE; Laskey J
J Toxicol Environ Health A; 2004 Apr; 67(7):537-53. PubMed ID: 15129551
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 isozymes involved in lisofylline metabolism to pentoxifylline in human liver microsomes.
Lee SH; Slattery JT
Drug Metab Dispos; 1997 Dec; 25(12):1354-8. PubMed ID: 9394024
[TBL] [Abstract][Full Text] [Related]
17. Biotransformation of 2,3,3,3-tetrafluoropropene (HFO-1234yf).
Schuster P; Bertermann R; Snow TA; Han X; Rusch GM; Jepson GW; Dekant W
Toxicol Appl Pharmacol; 2008 Dec; 233(2):323-32. PubMed ID: 18817801
[TBL] [Abstract][Full Text] [Related]
18. Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
Köster U; Speerschneider P; Kerssebaum R; Wittmann H; Dekant W
Drug Metab Dispos; 1994; 22(5):667-72. PubMed ID: 7835215
[TBL] [Abstract][Full Text] [Related]
19. Toxicokinetics and metabolism of N-[14C]methylpyrrolidone in male Sprague-Dawley rats. A saturable NMP elimination process.
Payan JP; Beydon D; Fabry JP; Boudry I; Cossec B; Ferrari E
Drug Metab Dispos; 2002 Dec; 30(12):1418-24. PubMed ID: 12433813
[TBL] [Abstract][Full Text] [Related]
20. The regulation of cytochrome P450 2E1 during LPS-induced inflammation in the rat.
Abdulla D; Goralski KB; Renton KW
Toxicol Appl Pharmacol; 2006 Oct; 216(1):1-10. PubMed ID: 16712892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
